Capital Health, Canada
16
0
0
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
12.5%
2 terminated/withdrawn out of 16 trials
85.7%
-0.8% vs industry average
44%
7 trials in Phase 3/4
8%
1 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Effects of Oral Iron on Postoperative Fatigue Upon Coronary Artery Bypass Graft Patients
Role: collaborator
Registry for Study of Coils in Intracranial Aneurysms
Role: collaborator
Comparison of Intravenous Cefazolin Plus Oral Probenecid With Oral Cephalexin for the Treatment of Cellulitis
Role: collaborator
Evaluation of Pregabalin in Idiopathic Small Fiber Neuropathy
Role: collaborator
MDS-CAN: A Prospective National MDS Clinical Database and Local Tissue Bank
Role: collaborator
Validation of an Exercise DVD for Maintenance After Pulmonary Rehabilitation.
Role: collaborator
The Safety and Efficacy of DCA for the Treatment of Brain Cancer
Role: collaborator
An Evaluation of the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate in Hemodialysis Patients
Role: collaborator
Use of COLD-fX to Prevent Respiratory Infections in Community Dwelling Seniors
Role: lead
Transcutaneous Bilirubinometers in the Community
Role: collaborator
Efficacy of Cold-FX (CVT-E002) in the Prevention of Upper Respiratory Tract Infections in Healthy Adults
Role: collaborator
Clinical Decision Unit (CDU) - Evaluation of a Novel Approach to Address Emergency Department Overcrowding
Role: collaborator
The Use of Continuous Wound Infusion Analgesia in Total Knee Arthroplasty
Role: lead
Improving Blood Pressure Management in Patients With Diabetes
Role: collaborator
Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team Environment
Role: collaborator
Pilot Evaluation of CVT-E002 in Pediatric Upper Respiratory Tract Infection.
Role: collaborator
All 16 trials loaded